Mingjian Lang
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Lipid metabolism and biosynthesis
Papers in
-
- Heart Failure Treatment and Management 3
- Cardiomyopathy and Myosin Studies 2
- Cardiovascular Function and Risk Factors 2
-
- Advanced biosensing and bioanalysis techniques 2
- Metabolism, Diabetes, and Cancer 2
- Co-authors
- Qingwei Ji (3 shared papers)Yudong Peng (3 shared papers)Wei Zhou (2 shared papers)Songnan Li (2 shared papers)Min Guo (2 shared papers)Bo Xiong (2 shared papers)Qiutang Zeng (2 shared papers)Xiaobo Mao (1 shared paper)
- Journals
- Medicine (2 papers)PLoS ONE (2 papers)RSC Advances (1 paper)International Immunopharmacology (1 paper)Cellular Physiology and Biochemistry (1 paper)
- Partner nations
- ChinaSouth KoreaUnited States
In The Last Decade
Mingjian Lang
16 papers receiving 333 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 106
- Biochemistry 23
- Molecular Biology 188
- Immunology 55
- Cardiology and Cardiovascular Medicine 54
Countries citing papers authored by Mingjian Lang
This map shows the geographic impact of Mingjian Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjian Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjian Lang more than expected).
Fields of papers citing papers by Mingjian Lang
This network shows the impact of papers produced by Mingjian Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjian Lang. The network helps show where Mingjian Lang may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingjian Lang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 98 | |
| 2 | 2013 | 47 | |
| 3 | 2020 | 39 | |
| 4 | 2008 | 35 | |
| 5 | 2013 | 20 | |
| 6 | 2014 | 18 | |
| 7 | 2021 | 17 | |
| 8 | 2010 | 13 | |
| 9 | 2016 | 11 | |
| 10 | 2020 | 10 | |
| 11 | 2022 | 8 | |
| 12 | Immune storm and coagulation storm in the pathogenesis of amniotic fluid embolism | 2021 | 6 |
| 13 | 2022 | 5 | |
| 14 | 2023 | 4 | |
| 15 | 2020 | 3 | |
| 16 | 2025 | 1 | |
| 17 | 2025 | 0 | |
| 18 | 2020 | 0 | |
| 19 | 2025 | 0 |
About Mingjian Lang
Mingjian Lang is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 19 papers that have together received 335 indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers), Advanced biosensing and bioanalysis techniques (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Cardiomyopathy and Myosin Studies (2 papers), T-cell and B-cell Immunology (2 papers), Cardiovascular Function and Risk Factors (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Cancer Research (106 citations), Biochemistry (23 citations), Molecular Biology (188 citations), Immunology (55 citations) and Cardiology and Cardiovascular Medicine (54 citations). Mingjian Lang has collaborated with scholars based in China, South Korea and United States. Frequent co-authors include Qingwei Ji, Yudong Peng, Wei Zhou, Songnan Li, Min Guo, Bo Xiong, Qiutang Zeng, Xiaobo Mao, Xiaobo Mao and Li Tian. Their work appears in journals such as Medicine, PLoS ONE, RSC Advances, International Immunopharmacology and Cellular Physiology and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.